UBS Group’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-156,254
| Closed | -$3.04M | – | 9563 |
|
|
2024
Q4 | $3.04M | Buy |
156,254
+78,270
| +100% | +$1.52M | ﹤0.01% | 3381 |
|
|
2024
Q3 | $1.22M | Buy |
+77,984
| New | +$1.22M | ﹤0.01% | 3435 |
|
|
2024
Q2 | – | Sell |
-73,646
| Closed | -$1.14M | – | 8973 |
|
|
2024
Q1 | $1.14M | Buy |
73,646
+1
| +0% | +$15 | ﹤0.01% | 3461 |
|
|
2023
Q4 | $1.02M | Hold |
73,645
| – | – | ﹤0.01% | 3420 |
|
|
2023
Q3 | $842K | Sell |
73,645
-82,344
| -53% | -$941K | ﹤0.01% | 3225 |
|
|
2023
Q2 | $3.88M | Sell |
155,989
-603
| -0.4% | -$15K | ﹤0.01% | 2108 |
|
|
2023
Q1 | $5.68M | Sell |
156,592
-90
| -0.1% | -$3.27K | ﹤0.01% | 1754 |
|
|
2022
Q4 | $9.45M | Buy |
156,682
+834
| +0.5% | +$50.3K | ﹤0.01% | 1420 |
|
|
2022
Q3 | $11.7M | Buy |
155,848
+4,782
| +3% | +$359K | 0.01% | 1194 |
|
|
2022
Q2 | $17.3M | Sell |
151,066
-1,125
| -0.7% | -$129K | 0.01% | 1038 |
|
|
2022
Q1 | $28.8M | Buy |
152,191
+148,494
| +4,017% | +$28.1M | 0.01% | 868 |
|
|
2021
Q4 | $1.28M | Buy |
3,697
+3,002
| +432% | +$1.04M | ﹤0.01% | 3253 |
|
|
2021
Q3 | $233K | Buy |
695
+692
| +23,067% | +$232K | ﹤0.01% | 4170 |
|
|
2021
Q2 | $3K | Buy |
+3
| New | +$3K | ﹤0.01% | 7747 |
|